bullish

Best Idea of 2025: Medexus Pharmaceuticals

190 Views03 Mar 2025 09:26
Medexus (MDP.TO / MEDXF) is my best idea for 2025. The stock trades at a distressed valuation despite the current launch of a new drug that could double revenue and triple EBITDA within 3 years.
What is covered in the Full Insight:
  • Introduction to Medexus Pharmaceuticals
  • Company Overview
  • GRAFAPEX Drug Launch and Market Potential
  • Financial Projections and Valuation
  • Risks and Investor Concerns
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top Quartile
Richard Howe
Founder at Stock Spin-off Investing
Stock Spin-Off Investing
Event-DrivenEquity Bottom-Up
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x